scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10147-011-0226-2 |
P698 | PubMed publication ID | 21437569 |
P2093 | author name string | Yoshihiko Hirao | |
Masahiro Tanaka | |||
Makito Miyake | |||
Kazumasa Torimoto | |||
Kiyohide Fujimoto | |||
Nobumichi Tanaka | |||
Keiji Shimada | |||
Noboru Konishi | |||
Akihide Hirayama | |||
Eijiro Okajima | |||
P2860 | cites work | Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathol | Q31163093 |
Trends of the primary therapy for patients with prostate cancer in Nara uro-oncological research group (NUORG): a comparison between the CaPSURE data and the NUORG data | Q33542941 | ||
Contemporary trends in low risk prostate cancer: risk assessment and treatment | Q34330041 | ||
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005 | Q36011880 | ||
The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review. | Q36661752 | ||
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer | Q43614751 | ||
Cancer control with radical prostatectomy alone in 1,000 consecutive patients | Q44200641 | ||
Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database | Q46649250 | ||
Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy | Q47729617 | ||
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer | Q48030260 | ||
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. | Q55067996 | ||
Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer | Q59650976 | ||
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer | Q73544131 | ||
Treatment outcome by risk group after radical prostatectomy in Japanese men | Q73965029 | ||
Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8 | Q79084204 | ||
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy | Q79917173 | ||
Contemporary evaluation of the D'amico risk classification of prostate cancer | Q80168461 | ||
Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy | Q80744531 | ||
Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy | Q80753568 | ||
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens | Q81044146 | ||
P433 | issue | 5 | |
P304 | page(s) | 553-559 | |
P577 | publication date | 2011-03-25 | |
P1433 | published in | International Journal of Clinical Oncology | Q15758148 |
P1476 | title | Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study. | |
P478 | volume | 16 |
Q35188264 | Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time |
Q44373070 | Efficiency of pretreatment risk stratification systems for prostate cancer in a Japanese population treated with radical prostatectomy |
Q41851526 | Factors effective on survival after radical prostatectomy: To what extent is pre-operative biopsy Gleason scoring is confident in predicting the prognosis? |
Q36575721 | Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? - The Cancer |
Q39035046 | Perineural Invasion and Risk of Lethal Prostate Cancer |
Q41905532 | Perineural invasion is an independent predictor of biochemical recurrence of prostate cancer after local treatment: a meta-analysis |
Q51021150 | Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients. |
Q34812281 | Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study |
Q35706065 | Review by urological pathologists improves the accuracy of Gleason grading by general pathologists |
Q35635497 | Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy |
Q42169535 | Significance of neoadjuvant hormonal therapy in radical retropubic prostatectomy: a retrospective single-surgeon study |
Q40680840 | Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy |
Q92436329 | The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions |
Search more.